Horien Biochemical Technology Co., Ltd. (7814.TWO)
Taipei Exchange · TWD · Healthcare · Biotechnology
NT$27.95 (-1.24%) as of
Key statistics
- Market cap
- 1.12B
- P/E (TTM)
- 215.00
- Forward P/E
- -349.38
- EPS (TTM)
- 0.13
- Dividend yield
- 0.00%
- 52-week range
- 27.45 – 45.40
- Profit margin
- 0.00%
- Volume
- 6.10k
About Horien Biochemical Technology Co., Ltd.
Horien Biochemical Technology Co., Ltd. operates as a supplier of cosmetic surgery raw materials and medical devices. The company develops collagen-based materials used in cosmetic applications, providing products, such as collagen dental matrix, gunne-plug, and extracellular membrane. Horien Biochemical Technology Co., Ltd. was founded in 2006 and is headquartered in Taichung, Taiwan.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Taichung, Taiwan
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.